drugset / Trial / NCT01589614

A Study To Investigate The Effect Of Erythromycin On The Pharmacokinetics Of PH-797804

NCT01589614

Phase 1 Completed 12 enrolled Pfizer
RandomizedCrossoverOpen-labelBasic science

Summary

The purpose of this study is to investigate the effect of co-administration with erythromycin on the time course of PH-797804 concentration in the blood following dosing by oral immediate release tablet formulation.

Timeline

Start
2012-06
Primary completion
2012-08
Completion
2012-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Erythromycin Small molecule 400 mg
Subject PH-797804 Small molecule 6 mg Oral

Indications

No indication recorded.